Gotham Asset Management LLC Grows Stock Position in Azenta, Inc. (NASDAQ:AZTA)

Gotham Asset Management LLC increased its position in shares of Azenta, Inc. (NASDAQ:AZTA) by 388.2% during the 4th quarter, Holdings Channel reports. The institutional investor owned 198,050 shares of the company’s stock after purchasing an additional 157,483 shares during the quarter. Gotham Asset Management LLC’s holdings in Azenta were worth $9,902,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Picton Mahoney Asset Management raised its position in Azenta by 305.7% in the fourth quarter. Picton Mahoney Asset Management now owns 706 shares of the company’s stock valued at $35,000 after purchasing an additional 532 shares during the period. Headlands Technologies LLC purchased a new stake in Azenta in the fourth quarter valued at approximately $40,000. Covestor Ltd raised its position in Azenta by 64.2% in the fourth quarter. Covestor Ltd now owns 2,043 shares of the company’s stock valued at $102,000 after purchasing an additional 799 shares during the period. KBC Group NV raised its position in Azenta by 48.5% in the fourth quarter. KBC Group NV now owns 2,137 shares of the company’s stock valued at $107,000 after purchasing an additional 698 shares during the period. Finally, Quarry LP purchased a new stake in Azenta in the fourth quarter valued at approximately $110,000. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Azenta Trading Down 3.2%

Azenta stock opened at $26.82 on Monday. Azenta, Inc. has a twelve month low of $23.91 and a twelve month high of $63.58. The stock’s fifty day simple moving average is $31.45 and its 200-day simple moving average is $42.03. The firm has a market capitalization of $1.23 billion, a P/E ratio of -9.00 and a beta of 1.64.

Azenta (NASDAQ:AZTA) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $0.05 earnings per share for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). Azenta had a positive return on equity of 1.25% and a negative net margin of 24.91%. During the same period in the previous year, the business posted $0.06 EPS. The firm’s quarterly revenue was up 5.1% on a year-over-year basis. Sell-side analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current year.

Wall Street Analyst Weigh In

AZTA has been the topic of a number of research analyst reports. TD Cowen raised Azenta to a “hold” rating in a research report on Thursday, February 27th. Needham & Company LLC cut their target price on Azenta from $59.00 to $40.00 and set a “buy” rating on the stock in a research report on Wednesday, May 7th. Finally, Evercore ISI boosted their target price on Azenta from $50.00 to $52.00 and gave the company an “in-line” rating in a research report on Thursday, February 6th.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.